These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1207 related items for PubMed ID: 16279906

  • 1. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J.
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [Abstract] [Full Text] [Related]

  • 2. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
    Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, Ball MJ, Seaton D, Brain T, Rasko JE.
    J Intern Med; 2010 Sep; 268(3):286-95. PubMed ID: 20546462
    [Abstract] [Full Text] [Related]

  • 3. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
    Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C.
    Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
    [Abstract] [Full Text] [Related]

  • 4. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
    Kim YH, Chung HH, Kang SB, Kim SC, Kim YT.
    Acta Haematol; 2009 May; 121(1):37-41. PubMed ID: 19332985
    [Abstract] [Full Text] [Related]

  • 5. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N, Russell R.
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [Abstract] [Full Text] [Related]

  • 6. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR.
    Arzneimittelforschung; 2010 Oct 23; 60(6a):386-98. PubMed ID: 20648930
    [Abstract] [Full Text] [Related]

  • 8. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
    Schröder O, Schrott M, Blumenstein I, Jahnel J, Dignass AU, Stein J.
    Z Gastroenterol; 2004 Aug 23; 42(8):663-7. PubMed ID: 15314711
    [Abstract] [Full Text] [Related]

  • 9. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F, Löhr B, Laubender RP, Tillack C, Schnitzler F, Breiteneicher S, Weidinger M, Göke B, Seiderer J, Ochsenkühn T, Brand S.
    Digestion; 2012 Aug 23; 85(1):47-54. PubMed ID: 22179489
    [Abstract] [Full Text] [Related]

  • 10. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B, Bhandari S, Barany P, Kalra PA, Ladefoged S, Wilske J, Thomsen LL.
    J Nephrol; 2011 Aug 23; 24(5):589-96. PubMed ID: 21240875
    [Abstract] [Full Text] [Related]

  • 11. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial.
    Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A.
    Obstet Gynecol; 2005 Dec 23; 106(6):1335-40. PubMed ID: 16319260
    [Abstract] [Full Text] [Related]

  • 12. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.
    Transfusion; 2009 Dec 23; 49(12):2719-28. PubMed ID: 19682342
    [Abstract] [Full Text] [Related]

  • 13. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
    Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, Petritsch W, Austrian Inflammatory Bowel Diseases Study Group.
    Am J Gastroenterol; 2001 Aug 23; 96(8):2382-7. PubMed ID: 11513178
    [Abstract] [Full Text] [Related]

  • 14. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
    McMahon LP, Kent AB, Kerr PG, Healy H, Irish AB, Cooper B, Kark A, Roger SD.
    Nephrol Dial Transplant; 2010 Mar 23; 25(3):920-6. PubMed ID: 19906658
    [Abstract] [Full Text] [Related]

  • 15. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia.
    Westad S, Backe B, Salvesen KA, Nakling J, Økland I, Borthen I, Rognerud Jensen OH, Kolås T, Løkvik B, Smedvig E.
    Acta Obstet Gynecol Scand; 2008 Mar 23; 87(9):916-23. PubMed ID: 18720044
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P, Banké-Bochita J.
    Arzneimittelforschung; 2010 Mar 23; 60(6a):362-72. PubMed ID: 20648928
    [Abstract] [Full Text] [Related]

  • 17. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O, Richard-Davis G, Morris T, Armstrong J.
    Clin Ther; 2007 Aug 23; 29(8):1682-91. PubMed ID: 17919549
    [Abstract] [Full Text] [Related]

  • 18. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Sinha S, Chiu DY, Peebles G, Kolakkat S, Lamerton E, Fenwick S, Kalra PA.
    J Ren Care; 2009 Jun 23; 35(2):67-73. PubMed ID: 19432851
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
    Pinsk V, Levy J, Moser A, Yerushalmi B, Kapelushnik J.
    Isr Med Assoc J; 2008 May 23; 10(5):335-8. PubMed ID: 18605353
    [Abstract] [Full Text] [Related]

  • 20. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U, Illigens BM, Siepmann T, Arneth B, Siegert G, Siegels D, Heigl F, Hettich R, Ramlow W, Prophet H, Bornstein SR, Julius U.
    Atheroscler Suppl; 2015 May 23; 18():199-208. PubMed ID: 25936327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.